— Know what they know.
Not Investment Advice

MDGL NASDAQ

Madrigal Pharmaceuticals, Inc.
1W: -4.9% 1M: -2.9% 3M: +18.1% YTD: -13.5% 1Y: +75.4% 3Y: +75.8% 5Y: +281.3%
$517.26
+3.67 (+0.71%)
 
Weekly Expected Move ±6.1%
$460 $492 $524 $555 $587
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 50 · $11.9B mcap · 21M float · 1.57% daily turnover · Short 67% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 934.3%
Cost Advantage ★
65
Intangibles
33
Switching Cost
40
Network Effect
47
Scale
34
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MDGL shows a Weak competitive edge (43.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 934.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$578
Low
$645
Avg Target
$709
High
Based on 3 analysts since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 20Hold: 2Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$645.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-13 Truist Financial $640 $709 +69 +38.1% $513.30
2026-05-07 Evercore ISI $405 $649 +244 +20.2% $539.73
2026-05-07 Canaccord Genuity $420 $578 +158 +7.1% $539.73
2026-01-27 Barclays Initiated $964 +92.6% $500.39
2026-01-14 Goldman Sachs Andrea Tan $375 $571 +196 +15.6% $493.90
2026-01-06 Wolfe Research Andy Chen Initiated $579 -1.6% $588.40
2025-12-19 Piper Sandler Yasmeen Rahimi $540 $900 +360 +52.9% $588.81
2025-12-19 UBS $410 $900 +490 +65.3% $544.41
2025-11-21 H.C. Wainwright $390 $620 +230 +11.0% $558.61
2025-11-20 Oppenheimer Jay Olson $590 $650 +60 +14.4% $568.01
2025-11-19 Truist Financial $580 $640 +60 +15.2% $555.60
2025-11-05 JMP Securities $397 $527 +130 +18.5% $444.64
2025-10-15 Piper Sandler $336 $540 +204 +23.5% $437.10
2025-10-14 Truist Financial Initiated $580 +32.7% $437.10
2025-10-10 Oppenheimer Jay Olson $250 $590 +340 +37.8% $428.30
2025-05-02 Canaccord Genuity Edward Nash Initiated $420 +33.1% $315.48
2024-05-29 Piper Sandler Yasmeen Rahimi Initiated $336 +51.5% $221.75
2024-05-09 H.C. Wainwright Ed Acre $425 $390 -35 +87.5% $208.04
2024-03-19 Evercore ISI Liisa Bayko Initiated $405 +52.4% $265.68
2024-03-15 UBS Eliana Merle $337 $410 +73 +51.6% $270.37
2024-03-15 Jefferies Akash Tewari Initiated $400 +47.9% $270.37
2024-03-15 H.C. Wainwright Ed Acre $225 $425 +200 +57.2% $270.37
2024-03-14 JMP Securities Jonathan Wolleben $390 $397 +7 +46.8% $270.37
2024-03-14 B.Riley Financial Mayank Mamtani Initiated $270 -0.1% $270.37
2023-01-05 JMP Securities $312 $390 +78 +42.1% $274.48
2022-12-21 UBS Initiated $337 +31.1% $257.12
2022-12-20 H.C. Wainwright Initiated $225 -10.5% $251.50
2022-12-20 Oppenheimer Initiated $250 +3.3% $242.00
2022-12-20 Goldman Sachs $195 $375 +180 +59.7% $234.83
2022-12-20 JMP Securities Initiated $312 +32.9% $234.83
2022-12-20 Leerink Partners Initiated $315 +34.1% $234.83
2021-08-05 BMO Capital Matthew Luchini Initiated $111 +22.0% $90.95
2021-05-19 Goldman Sachs Andrea Tan Initiated $195 +50.3% $129.77
2021-05-05 Wells Fargo Derek Archila Initiated $130 +2.6% $126.71

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MDGL receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-11 C+ C
2026-05-06 C C+
2026-03-25 C- C
2026-02-23 C C-
2026-02-20 C- C
2026-01-08 C C-
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

50 Grade D
Profitability
20
Balance Sheet
51
Earnings Quality
63
Growth
85
Value
32
Momentum
78
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MDGL scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
12.59
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
-1.15
Possible Manipulator
Ohlson O-Score
-6.19
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BBB+
Score: 61.0/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.87x
Accruals: -3.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MDGL scores 12.59, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MDGL scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MDGL's score of -1.15 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MDGL's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MDGL receives an estimated rating of BBB+ (score: 61.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-48.53x
PEG
-1.66x
P/S
10.53x
P/B
27.63x
P/FCF
-55.79x
P/OCF
EV/EBITDA
-50.65x
EV/Revenue
12.86x
EV/EBIT
-50.45x
EV/FCF
-53.48x
Earnings Yield
-2.04%
FCF Yield
-1.79%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MDGL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.072
EBT / EBIT
×
EBIT Margin
-0.255
EBIT / Rev
×
Asset Turnover
0.984
Rev / Assets
×
Equity Multiplier
1.696
Assets / Equity
=
ROE
-45.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MDGL's ROE of -45.6% is driven by Asset Turnover (0.984), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$517.26
Median 1Y
$479.10
5th Pctile
$156.43
95th Pctile
$1492.23
Ann. Volatility
73.8%
Analyst Target
$645.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Bill Sibold
President and Chief Executive Officer
$889,583 $7,558,495 $12,214,250
Mardi Dier Financial
Vice President and Chief Financial Officer
$464,679 $5,676,894 $8,751,912
Rebecca Taub, M.D.
Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer
$596,209 $3,570,078 $5,967,206
Alex Howarth Financial
nior Vice President and Chief Financial Officer
$294,547 $2,963,547 $5,242,872
Shannon Kelley Legal
tive Vice President and Chief Legal Counsel
$441,655 $1,949,994 $4,673,764
Brian J. Lynch
Former Senior Vice President and General Counsel
$380,109 $2,245,336 $4,250,806
Carole Huntsman Commercial
Vice President and Chief Commercial Officer
$525,000 $2,245,336 $3,949,441

CEO Pay Ratio

14:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $12,214,250
Avg Employee Cost (SGA/emp): $889,428
Employees: 915

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
915
+73.3% YoY
Revenue / Employee
$1,047,435
Rev: $958,403,000
Profit / Employee
$-315,064
NI: $-288,284,000
SGA / Employee
$889,428
Avg labor cost proxy
R&D / Employee
$424,617
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -70.5% -72.0% -1.1% -1.1% -1.2% -1.3% -1.5% -1.6% -1.7% -1.8% -1.2% -1.5% -1.7% -1.7% -80.3% -67.5% -48.6% -49.9% -42.5% -45.6% -45.60%
ROA -63.4% -64.9% -86.3% -88.1% -91.3% -97.8% -92.9% -99.0% -1.0% -1.1% -74.5% -88.6% -1.0% -1.0% -55.4% -46.5% -33.5% -34.4% -25.0% -26.9% -26.89%
ROIC 4.2% 4.3% 2.6% 2.7% 2.7% 2.9% 2.1% 2.2% 2.3% 2.5% 2.7% 3.2% 3.8% 3.9% 7.5% 6.4% 4.7% 4.6% 8.9% 9.3% 9.34%
ROCE -96.9% -98.7% -1.2% -1.3% -1.3% -1.4% -1.2% -1.3% -1.3% -1.4% -69.1% -82.4% -94.9% -96.5% -51.7% -43.2% -30.7% -31.1% -28.0% -30.4% -30.42%
Gross Margin 95.7% 96.5% 96.7% 96.7% 95.7% 93.7% 92.4% 91.4% 91.38%
Operating Margin -11.1% -1.9% -64.8% -57.8% -22.2% -39.7% -18.6% -29.8% -29.78%
Net Margin -10.4% -1.7% -57.5% -53.4% -19.9% -39.8% -18.2% -30.3% -30.32%
EBITDA Margin -10.1% -1.7% -53.8% -50.7% -18.2% -37.0% -15.5% -29.8% -29.78%
FCF Margin -31.1% -5.7% -2.6% -1.3% -59.8% -21.8% -19.8% -24.1% -24.05%
OCF Margin -30.7% -5.6% -2.5% -1.2% -59.6% -21.7% -19.8% -23.7% -23.67%
ROE 3Y Avg snapshot only -70.95%
ROE 5Y Avg snapshot only -99.63%
ROA 3Y Avg snapshot only -43.83%
ROIC Economic snapshot only -26.51%
Cash ROA snapshot only -21.28%
NOPAT Margin snapshot only -21.87%
Pretax Margin snapshot only -27.32%
R&D / Revenue snapshot only 40.00%
SGA / Revenue snapshot only 80.75%
SBC / Revenue snapshot only 7.54%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -6.98 -5.62 -5.98 -6.80 -4.78 -4.06 -16.94 -14.00 -12.83 -7.77 -12.24 -12.02 -11.75 -8.90 -14.52 -18.69 -23.84 -35.67 -45.32 -49.11 -48.531
P/S Ratio 409.63 60.08 37.57 23.06 13.04 13.92 13.63 13.42 10.531
P/B Ratio 6.73 5.53 7.38 8.56 6.24 5.67 25.35 22.32 21.43 13.67 11.28 13.18 14.79 11.39 8.97 9.70 8.91 13.67 21.68 25.22 27.633
P/FCF -8.36 -6.95 -7.86 -8.80 -6.08 -5.18 -22.23 -17.00 -15.26 -8.90 -14.04 -13.66 -13.15 -10.53 -14.65 -18.23 -21.79 -63.80 -68.75 -55.79 -55.789
P/OCF
EV/EBITDA -5.72 -4.41 -4.87 -5.72 -3.75 -3.10 -16.14 -13.31 -12.22 -7.10 -11.25 -11.23 -11.07 -8.15 -13.24 -17.31 -22.17 -35.19 -47.02 -50.65 -50.650
EV/Revenue 374.32 53.35 33.09 20.51 11.47 12.83 12.97 12.86 12.864
EV/EBIT -5.71 -4.40 -4.86 -5.71 -3.74 -3.10 -16.11 -13.28 -12.20 -7.09 -11.24 -11.22 -11.06 -8.14 -13.21 -17.25 -22.05 -35.00 -46.75 -50.45 -50.452
EV/FCF -6.89 -5.47 -6.39 -7.39 -4.75 -3.92 -20.86 -15.81 -14.15 -7.88 -12.45 -12.33 -12.02 -9.35 -12.90 -16.22 -19.18 -58.81 -65.44 -53.48 -53.479
Earnings Yield -14.3% -17.8% -16.7% -14.7% -20.9% -24.6% -5.9% -7.1% -7.8% -12.9% -8.2% -8.3% -8.5% -11.2% -6.9% -5.4% -4.2% -2.8% -2.2% -2.0% -2.04%
FCF Yield -12.0% -14.4% -12.7% -11.4% -16.4% -19.3% -4.5% -5.9% -6.6% -11.2% -7.1% -7.3% -7.6% -9.5% -6.8% -5.5% -4.6% -1.6% -1.5% -1.8% -1.79%
Price/Tangible Book snapshot only 25.529
EV/Gross Profit snapshot only 13.822
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.13 6.13 3.54 3.54 3.54 3.54 3.12 3.12 3.12 3.12 5.38 5.38 5.38 5.38 6.10 6.10 6.10 6.10 4.01 4.01 4.015
Quick Ratio 6.13 6.13 3.54 3.54 3.54 3.54 3.12 3.12 3.12 3.12 5.38 5.38 5.38 5.38 5.90 5.90 5.90 5.90 3.77 3.77 3.774
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.25 0.25 0.25 0.29 0.29 0.29 0.29 0.16 0.16 0.16 0.16 0.59 0.59 0.588
Net Debt/Equity -1.18 -1.18 -1.37 -1.37 -1.37 -1.37 -1.56 -1.56 -1.56 -1.56 -1.28 -1.28 -1.28 -1.28 -1.07 -1.07 -1.07 -1.07 -1.04 -1.04 -1.044
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.14 0.14 0.14 0.18 0.18 0.18 0.18 0.11 0.11 0.11 0.11 0.28 0.28 0.281
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.17 -0.16 -0.16 -0.15 -0.33 -0.27 -0.24 -0.23 -0.27 -0.32 -0.45 -0.44 -1.34 -1.23 -1.232
Net Debt/EBITDA 1.22 1.20 1.11 1.09 1.06 0.99 1.06 1.00 0.96 0.92 1.43 1.20 1.04 1.03 1.79 2.14 3.02 2.99 2.38 2.19 2.188
Interest Coverage -327.14 -119.09 -73.51 -48.96 -38.16 -32.32 -28.39 -30.26 -33.10 -33.25 -30.75 -26.71 -19.52 -15.51 -11.92 -10.76 -10.762
Equity Multiplier 1.20 1.20 1.39 1.39 1.39 1.39 1.84 1.84 1.84 1.84 1.58 1.58 1.58 1.58 1.38 1.38 1.38 1.38 2.09 2.09 2.090
Cash Ratio snapshot only 3.170
Debt Service Coverage snapshot only -10.720
Cash to Debt snapshot only 2.776
FCF to Debt snapshot only -0.769
Defensive Interval snapshot only 298.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.15 0.21 0.38 0.61 0.88 0.83 0.98 0.984
Inventory Turnover 0.37 0.63 1.13 2.06 1.03 1.44 1.441
Receivables Turnover 6.69 11.79 19.16 27.52 10.18 12.03 12.029
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.03 0.11 0.17 0.30 0.54 0.98 1.21 1.70 1.697
DSO 0 0 55 31 19 13 36 30 30.3 days
DIO 0 0 0 0 997 579 324 177 354 253 253.3 days
DPO 66666 66666 12168 3231 2098 1217 682 372 301 215 215.0 days
Cash Conversion Cycle -12168 -3231 -1046 -607 -339 -182 89 69 68.6 days
Fixed Asset Turnover snapshot only 175.907
Operating Cycle snapshot only 283.6 days
Cash Velocity snapshot only 1.151
Capital Intensity snapshot only 1.112
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 34.2% 8.6% 4.3% 2.6% 2.57%
Net Income -72.2% -38.4% -19.6% -12.9% -10.6% -15.9% -22.1% -27.5% -28.9% -26.8% -26.5% -41.2% -54.8% -49.3% -24.7% 11.9% 44.8% 44.3% 38.1% 21.0% 20.98%
EPS -60.4% -28.5% -8.4% -4.5% -7.2% -12.8% -21.0% -19.9% -20.4% -17.3% -10.3% -28.4% -32.4% -26.9% -12.4% 20.2% 46.8% 46.1% 39.5% 39.9% 39.87%
FCF -1.5% -65.5% -16.6% -11.8% -4.2% -12.5% -22.2% -36.0% -37.7% -41.3% -44.7% -50.9% -64.5% -44.5% -41.9% -2.6% 32.3% 63.1% 58.9% 32.1% 32.14%
EBITDA -66.8% -34.1% -17.3% -11.4% -9.6% -14.5% -20.3% -24.9% -26.0% -24.0% -23.9% -39.5% -54.2% -49.4% -24.9% 12.4% 46.1% 46.3% 41.2% 23.5% 23.53%
Op. Income -63.6% -34.1% -17.3% -11.5% -9.7% -14.9% -21.1% -27.2% -29.3% -27.8% -29.6% -44.5% -60.5% -57.2% -30.8% 6.4% 41.6% 43.9% 39.7% 26.3% 26.26%
OCF Growth snapshot only 32.18%
Asset Growth snapshot only 20.85%
Equity Growth snapshot only -20.11%
Debt Growth snapshot only 1.96%
Shares Change snapshot only 31.42%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 14.3% 14.3% -17.4% -17.4% -17.4% -17.4% -6.4% -6.4% -6.4% -6.4% 30.7% 30.7% 30.7% 30.7% 56.2% 56.2% 56.2% 56.2% 51.5% 51.5% 51.45%
Assets 5Y 33.3% 33.3% 46.0% 46.0% 46.0% 46.0% 13.5% 13.5% 13.5% 13.5% 5.7% 5.7% 5.7% 5.7% 18.7% 18.7% 18.7% 18.7% 34.4% 34.4% 34.42%
Equity 3Y 9.6% 9.6% -25.6% -25.6% -25.6% -25.6% -22.0% -22.0% -22.0% -22.0% 19.1% 19.1% 19.1% 19.1% 56.7% 56.7% 56.7% 56.7% 45.1% 45.1% 45.07%
Book Value 3Y 4.6% 6.6% -28.2% -28.3% -28.2% -28.2% -24.9% -26.2% -26.4% -26.6% 9.8% 10.2% 9.4% 8.9% 44.1% 43.9% 43.6% 43.0% 32.9% 24.1% 24.13%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.41 0.41 0.41 0.41 0.43 0.48 0.53 0.58 0.579
Earnings Stability 0.73 0.80 0.84 0.87 0.90 0.94 0.95 0.96 0.98 0.98 0.98 0.97 0.95 0.95 0.98 0.89 0.49 0.46 0.44 0.41 0.407
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.85 0.92 0.95 0.96 0.94 0.91 0.89 0.88 0.89 0.89 0.84 0.50 0.80 0.90 0.95 0.82 0.82 0.85 0.92 0.916
Earnings Smoothness
ROE Trend -0.75 -0.71 -0.71 -0.68 -0.66 -0.70 -0.46 -0.51 -0.54 -0.57 0.44 0.33 0.23 0.30 0.59 0.83 1.09 1.14 0.29 0.29 0.294
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.83 0.81 0.76 0.77 0.79 0.78 0.76 0.82 0.84 0.87 0.87 0.88 0.88 0.83 0.98 1.01 1.09 0.56 0.66 0.87 0.866
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.02 1.01 1.02 1.00 1.01 1.00 1.02 1.016
FCF/Net Income snapshot only 0.880
CapEx/Revenue 46.9% 9.5% 3.6% 1.9% 0.2% 0.1% 0.0% 0.4% 0.38%
CapEx/Depreciation snapshot only 2.853
Accruals Ratio -0.10 -0.13 -0.21 -0.20 -0.20 -0.21 -0.22 -0.18 -0.17 -0.14 -0.10 -0.11 -0.12 -0.17 -0.01 0.00 0.03 -0.15 -0.09 -0.04 -0.036
Sloan Accruals snapshot only 0.061
Cash Flow Adequacy snapshot only -62.117
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -8.1% -11.4% -11.8% -6.2% -3.3% -1.7% -5.1% -5.8% -6.6% -10.4% -5.7% -10.7% -10.6% -13.7% -5.9% -1.3% -0.0% -0.2% -0.2% -0.1% -0.14%
Total Shareholder Return -8.1% -11.4% -11.8% -6.2% -3.3% -1.7% -5.1% -5.8% -6.6% -10.4% -5.7% -10.7% -10.6% -13.7% -5.9% -1.3% -0.0% -0.2% -0.2% -0.1% -0.14%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.99 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.03 1.03 1.04 1.03 1.03 1.03 1.03 1.04 1.05 1.06 1.08 1.07 1.072
EBIT Margin -33.85 -6.56 -2.50 -1.19 -0.52 -0.37 -0.28 -0.25 -0.255
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.15 0.21 0.38 0.61 0.88 0.83 0.98 0.984
Equity Multiplier 1.11 1.11 1.28 1.28 1.28 1.28 1.62 1.62 1.62 1.62 1.66 1.66 1.66 1.66 1.45 1.45 1.45 1.45 1.70 1.70 1.696
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-13.96 $-14.21 $-14.16 $-14.43 $-14.96 $-16.02 $-17.13 $-17.30 $-18.01 $-18.80 $-18.91 $-22.21 $-23.85 $-23.85 $-21.25 $-17.73 $-12.69 $-12.86 $-12.85 $-10.66 $-10.66
Book Value/Share $14.48 $14.42 $11.49 $11.47 $11.47 $11.47 $11.45 $10.85 $10.78 $10.68 $20.51 $20.26 $18.94 $18.64 $34.40 $34.15 $33.97 $33.55 $26.86 $20.76 $18.72
Tangible Book/Share $14.48 $14.42 $11.49 $11.47 $11.47 $11.47 $11.45 $10.85 $10.78 $10.68 $20.51 $20.26 $18.94 $18.64 $34.18 $33.93 $33.76 $33.34 $26.54 $20.50 $20.50
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.68 $3.53 $8.21 $14.37 $23.22 $32.94 $42.72 $39.01 $39.01
FCF/Share $-11.66 $-11.47 $-10.78 $-11.15 $-11.76 $-12.55 $-13.06 $-14.25 $-15.13 $-16.41 $-16.48 $-19.55 $-21.30 $-20.16 $-21.07 $-18.17 $-13.89 $-7.19 $-8.47 $-9.38 $-9.38
OCF/Share $-11.65 $-11.47 $-10.77 $-11.13 $-11.75 $-12.54 $-13.04 $-14.24 $-15.13 $-16.39 $-16.41 $-19.46 $-20.98 $-19.82 $-20.77 $-17.89 $-13.84 $-7.14 $-8.45 $-9.23 $-9.23
Cash/Share $17.15 $17.08 $15.83 $15.81 $15.81 $15.81 $20.81 $19.73 $19.59 $19.42 $32.09 $31.70 $29.63 $29.16 $42.24 $41.93 $41.71 $41.20 $43.84 $33.88 $28.17
EBITDA/Share $-14.03 $-14.24 $-14.17 $-14.41 $-14.89 $-15.86 $-16.88 $-16.93 $-17.52 $-18.21 $-18.24 $-21.47 $-23.12 $-23.11 $-20.53 $-17.03 $-12.01 $-12.02 $-11.79 $-9.91 $-9.91
Debt/Share $0.05 $0.05 $0.05 $0.05 $0.05 $0.05 $2.89 $2.74 $2.72 $2.70 $5.93 $5.86 $5.48 $5.39 $5.45 $5.41 $5.38 $5.32 $15.80 $12.21 $12.21
Net Debt/Share $-17.10 $-17.03 $-15.79 $-15.76 $-15.76 $-15.76 $-17.92 $-16.98 $-16.87 $-16.72 $-26.16 $-25.84 $-24.15 $-23.77 $-36.79 $-36.52 $-36.33 $-35.88 $-28.05 $-21.67 $-21.67
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 12.592
Altman Z-Prime snapshot only 22.213
Piotroski F-Score 1 1 1 1 1 1 2 2 2 2 4 3 4 4 5 4 5 5 4 4 4
Beneish M-Score 9.99 0.41 -0.87 -1.15 -1.153
Ohlson O-Score snapshot only -6.194
ROIC (Greenblatt) snapshot only -30.66%
Net-Net WC snapshot only $20.28
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 74.02 73.71 74.12 74.77 60.06 53.07 64.20 63.78 63.97 61.01 64.16 63.74 64.00 63.89 65.58 65.67 65.68 65.63 61.48 60.98 60.983
Credit Grade snapshot only 8
Credit Trend snapshot only -4.684
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 55
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms